MedTrace Logo

The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease

NCT00431418 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-09-23

No results posted yet for this study

Summary

The purpose of this pilot study is to investigate in a randomised double-blind trial whether treatment with Sildenafil reduces duration of ventilatory support in preterm infants born at 28 weeks of gestation or less.

Conditions

  • Lung Diseases

Interventions

DRUG

Sildenafil

Sildenafil oral solution

DRUG

Placebo

Placebo solution

Sponsors & Collaborators

  • Mercy Hospital for Women, Australia

    lead OTHER

Principal Investigators

  • Kai König, MD · Mercy Hospital for Women

  • Charles P Barfield, MD · Mercy Hospital for Women

  • Chad C Andersen, MD · Mercy Hospital for Women

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2010-07-31
Completion
2012-06-30

Countries

  • Australia

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00431418 on ClinicalTrials.gov